Faisal Sadaf, Ivo Jessica, Abu Fadaleh Sarah, Patel Tejal
School of Pharmacy, University of Waterloo, Kitchener, ON N2G 1C5, Canada.
Centre for Family Medicine Family Health Team, Kitchener, ON N2G 1C5, Canada.
Pharmacy (Basel). 2023 Jan 18;11(1):18. doi: 10.3390/pharmacy11010018.
Smart adherence products enable the monitoring of medication intake in real-time. However, the value of real-time medication intake monitoring to different stakeholders such as patients, their caregivers, clinicians, and insurers is not elucidated. The aim of this study was to explore the value different stakeholders place on the availability of smart adherence products and access to real-time medication intake data. A qualitative study design using semi-structured one-on-one virtual interviews was utilized. Schwartz's theory of values provided the foundation for the interview questions, data were analyzed using Braun and Clark's thematic analysis framework, and findings were mapped back to the constructs of Schwartz's theory of values. A total of 31 interviews with patients, caregivers, healthcare providers, and representatives of private or public insurance providers were conducted. Three themes and ten subthemes were identified. Themes included perceptions of integrating smart medication adherence technologies and real-time monitoring, technology adoption factors and data management. Stakeholders place different values based on the motivators and goals that can drive product use for daily medication management. Stakeholders valued the availability of real-time medication taking data that allow clinicians to make timely data-driven recommendations to their patients that may improve medication management for patients and reduce the caregiver burden.
智能依从性产品能够实时监测药物摄入情况。然而，实时药物摄入监测对于患者、其护理人员、临床医生和保险公司等不同利益相关者的价值尚未得到阐明。本研究的目的是探讨不同利益相关者对智能依从性产品的可用性以及获取实时药物摄入数据的重视程度。采用了定性研究设计，通过半结构化的一对一虚拟访谈进行。施瓦茨的价值观理论为访谈问题提供了基础，使用布劳恩和克拉克的主题分析框架对数据进行分析，并将研究结果映射回施瓦茨的价值观理论结构。总共对患者、护理人员、医疗保健提供者以及私人或公共保险提供者的代表进行了31次访谈。确定了三个主题和十个子主题。主题包括对整合智能药物依从性技术和实时监测的看法、技术采用因素和数据管理。利益相关者根据能够推动产品用于日常药物管理的动机和目标赋予不同的价值。利益相关者重视实时服药数据的可用性，这些数据使临床医生能够及时向患者提出基于数据的建议，这可能会改善患者的药物管理并减轻护理人员的负担。
